Detalhe da pesquisa
1.
Corrigendum to "Bleomycin induced lung fibrosis increases work of breathing in the mouse" [Pulm. Pharmacol.Therapeut. 25 (2012) 281-285].
Pulm Pharmacol Ther
; 73-74: 102122, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248466
2.
Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.
Am J Pathol
; 183(2): 470-9, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23759512
3.
BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.
Mol Pharmacol
; 83(1): 283-93, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23115324
4.
Bleomycin induced lung fibrosis increases work of breathing in the mouse.
Pulm Pharmacol Ther
; 25(4): 281-5, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22024054
5.
CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40.
PLoS One
; 15(3): e0228221, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32155151
6.
Near infrared readouts offer sensitive and rapid assessments of intestinal permeability and disease severity in inflammatory bowel disease models.
Sci Rep
; 10(1): 4696, 2020 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170183
7.
House dust mite models: will they translate clinically as a superior model of asthma?
J Allergy Clin Immunol
; 132(1): 242-4, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23403050
8.
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Cancer Res
; 63(5): 965-71, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12615710
9.
Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma.
J Aerosol Med Pulm Drug Deliv
; 29(3): 233-41, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27111445
10.
Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
PLoS One
; 8(4): e59348, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23565148
11.
Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.
J Med Chem
; 55(17): 7920-39, 2012 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22894757